Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRP with topical minoxidil is the most effective for increasing hair density in male pattern baldness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

New therapies are being developed that target integrin pathways to treat various diseases.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

CD4+ skin cells may be precursors to basal cell carcinoma.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

New treatments for skin and hair repair show promise, but further improvements are needed.

CD2 might be a new treatment target for patchy alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Non-immune factors play a significant role in alopecia areata.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

CT60 polymorphism might increase the risk of Alopecia Areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.